SAN FRANCISCO, March 4, 2024 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR), a biotechnology company developing medicines for the treatment of auto-immune disorders, today announced that it has entered into a securities purchase agreement with TCGX, an institutional accredited investor, to sell securities in a private placement financing (the “PIPE”) for gross…Read More
Hustle engaged FLG when we started scaling rapidly after our Series B. Patty Fukami joined our team and seemingly overnight leveled up our entire Finance operation, including accounting, billing, and FP&A. Beyond that, she has been a true partner to me as CEO in growing the business and has become a highly respected leader at the company, shifting Hustle’s entire culture to be more financially prudent and to make better decisions for the long-term financial health of the business.
Roddy Lindsay, CEO and Co-founder, Hustle Read More